title: Reply: To PMID 24531021.
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Woohyok
authors.initials: W
authors.lastname: Chang
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Sunir J
authors.initials: SJ
authors.lastname: Garg
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Jason
authors.initials: J
authors.lastname: Hsu
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Arunan
authors.initials: A
authors.lastname: Sivalingam
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Seema A
authors.initials: SA
authors.lastname: Gupta
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Carl D
authors.initials: CD
authors.lastname: Regillo
authors.affiliation: Philadelphia, Pennsylvania.
authors.forename: Allen C
authors.initials: AC
authors.lastname: Ho
authors.affiliation: Indianapolis, Indiana.
authors.forename: Raj
authors.initials: R
authors.lastname: Maturi
mesh_terms: D058450:Endotamponade; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012166:Retinal Hemorrhage / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014821:Vitrectomy; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator